While AI can be effective in some elements of drug design, AI models currently struggle to explain their decision making, a key component of drug review.
After regional public health collaboratives formed in September, New York could be the first state to formally shift policies away from deferring to federal guidelines.
What are the latest developments in climate change, and how does it continue to impact front-line workers such as ocean workers and construction workers?
With the Trump Administration’s new tariff on prescription medications, how are drug manufacturers reacting, and how might the workers’ compensation system be impacted?
Patients taking semaglutide or tirzepatide had a more than 40% lower risk of hospitalization for heart failure compared with patients taking drugs to lower blood sugar.
CEO Daryl Corr and SVP Todd Piscoitti were featured in WorkCompWire’s Leaders Speak series, while VP of Clinical Services, Silvia Sacalis’ recaps her National Comp presentation.
In workers’ comp, comorbidities like hypertension require a focus on drug-drug and drug-disease interactions to ensure effective and safe treatment plans.
More complex and costly claims have become a persistent issue in workers’ compensation. See what drives longer claim duration and higher costs and how to mitigate risk factors.
While the global cancer burden continues to rise, the risk and impact of occupational cancers can vary significantly depending on the nature of the exposure and the affected workforce. For payers who are impacted, the costs can be substantial.
